IN-VITRO SUSCEPTIBILITIES OF BORDETELLA-PERTUSSIS AND BORDETELLA-PARAPERTUSSIS TO 2 KETOLIDES (HMR-3004 AND HMR-3647), 4 MACROLIDES (AZITBROMYCIN, CLARITHROMYCIN, ERYTHROMYCIN-A, AND ROXITHROMYCIN), AND 2 ANSAMYCINS (RIFAMPIN AND RIFAPENTINE)

Citation
Je. Hoppe et A. Bryskier, IN-VITRO SUSCEPTIBILITIES OF BORDETELLA-PERTUSSIS AND BORDETELLA-PARAPERTUSSIS TO 2 KETOLIDES (HMR-3004 AND HMR-3647), 4 MACROLIDES (AZITBROMYCIN, CLARITHROMYCIN, ERYTHROMYCIN-A, AND ROXITHROMYCIN), AND 2 ANSAMYCINS (RIFAMPIN AND RIFAPENTINE), Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 965-966
Citations number
11
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
ISSN journal
00664804
Volume
42
Issue
4
Year of publication
1998
Pages
965 - 966
Database
ISI
SICI code
0066-4804(1998)42:4<965:ISOBAB>2.0.ZU;2-0
Abstract
When tested by agar dilution on Mueller-Hinton agar supplemented with 5% horse blood, the ketolides HMR 3004 and HMR 3647 were slightly more active (MIC at which 90% of the isolates were inhibited [MIC90], 0.03 mu g/ml) against Bordetella pertussis than azithromycin, clarithromyc in, erythromycin A, and roxithromycin. Azithromycin (MIC90, 0.06 mu g/ ml) was the most active compound against B. parapertussis. Rifampin an d rifapentine were considerably less active.